Danielle Juliano, LCSW-C | |
5 Alexander Chase Apt D, Sparks Glencoe, MD 21152-9010 | |
(410) 967-5036 | |
Not Available |
Full Name | Danielle Juliano |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 5 Alexander Chase Apt D, Sparks Glencoe, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427530898 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 15174 (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Danielle Juliano, LCSW-C 5 Alexander Chase, Sparks Glencoe, MD 21152-9009 Ph: (410) 967-5036 | Danielle Juliano, LCSW-C 5 Alexander Chase Apt D, Sparks Glencoe, MD 21152-9010 Ph: (410) 967-5036 |
News Archive
"Several American aid groups are criticizing the U.S. government delay on deciding whether to resume large-scale food donations to North Korea" after recent flooding deteriorated health and food security in the country, VOA News reports.
Genesis HealthCare, one of the nation's largest providers of post-acute care services, today announced that it has signed a definitive agreement to combine with Skilled Healthcare Group, Inc., based in Foothill Ranch, California.
MD Biosciences, Inc. Clinical and Diagnostic Services Laboratory announces the release of its rapid assay to detect the virus in human blood and urine samples. The nucleic acid test can be performed in a few hours in blood, plasma, serum or urine samples.
Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the power of biologics, today announced the initiation of a two-part research and development collaboration with Novartis.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer.
› Verified 4 days ago
Mikhel Kushner, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15 Victoria Falls Ct, Sparks Glencoe, MD 21152 Phone: 443-503-4374 |